Companies: 10,795·Total market cap: $144.5T
Bioasis Technologies Inc.

Bioasis Technologies Inc.

BIOAFOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$7941
P/E Ratio
52W High$0.0002
52W Low$0.0001

Bioasis Technologies Inc. (BIOAF) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

bioaf · pe ratio · data through Feb 28, 2022

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Bioasis Technologies Inc. (BIOAF) measures how much investors pay for each dollar of the company's trailing earnings. BIOAF's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.04.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2022-02-28

Forward P/E
N/A
FY2025 est. EPS $-0.07
Based on 1 analyst
EPS (TTM)
-$0.04
TTM · diluted EPS
PEG Ratio
-0.01
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Bioasis Technologies Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2007 – 2022 · Annual
PE Ratio (TTM)
5Y Avg 38.1x
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Biotechnology · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Bioasis Technologies Inc.
Bioasis Technologies Inc.You
BIOAF
$0MN/A-$0.04
BioLife Sciences Inc.
BioLife Sciences Inc.
BLFE
$0MN/A-$0.02
Banyan Corp.
Banyan Corp.
BNYN
$0MN/A-$17.79
Easy Technologies Inc.
Easy Technologies Inc.
EMYSF
$0MN/A-$0.07
GB Sciences, Inc.
GB Sciences, Inc.
GBLX
$0MN/A-$0.00
GlobeStar Therapeutics Corporation
GlobeStar Therapeutics Corporation
GSTC
$0MN/A-$0.00
IR Biosciences Holdings Inc.
IR Biosciences Holdings Inc.
IRBS
$0MN/A-$0.31

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 16 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2022-02-28Latest
FY2022
$-0.04
2021-02-28
FY2021
38.08x$0.01
2020-02-28
FY2020
$-0.07
2019-02-28
FY2019
$-0.06
2018-02-28
FY2018
$-0.10
2017-02-28
FY2017
$-0.07
2016-02-28
FY2016
$-0.06
2015-02-28
FY2015
$-0.07
2014-02-28
FY2014
$-0.09
2013-02-28
FY2013
$-0.13

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Bioasis Technologies Inc. (BIOAF) measures how much investors pay for each dollar of the company's trailing earnings. BIOAF's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.04.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.00 ÷ -$0.04 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

BIOAF pe ratio · 6 questions

BIOAF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.04. Data sourced from Financial Modeling Prep via BIOAF's SEC 10-K and 10-Q filings.

BIOAF PE ratioWhat is BIOAF PE ratioCurrent PE ratio of BIOAFBIOAF PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Bioasis Technologies Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09